OBJECTIVE	The pharmacokinetics of 6-mercaptopurine , including cerebrospinal-fluid ( CSF ) distribution , and the erythrocyte 6-thioguanine nucleotide concentrations were determined in children randomised to receive intravenous mercaptopurine for acute lymphoblastic leukaemia ( ALL ) , according to the EORTC protocol ALL n. 58881 .\